GDP-validated pharma warehouse — UAE
Regional distributor for vaccines, biologics and oncology needed a GDP-compliant facility with redundant cooling, controlled access and full audit trail.
Challenge
- Zero-downtime requirement during summer (45 °C+ ambient).
- Validation timeline tied to Ministry of Health licensing.
- Mixed +2/+8 °C and −20 °C zones in the same building envelope.
ColdMatch solution
- Dual-redundant chillers with N+1 architecture and 24h backup.
- Calibrated mapping, 21 CFR Part 11 monitoring, validated SOPs.
- ColdMatch coordinated WHO/GDP commissioning with the EPC.
How this project was delivered — planning to commissioning
Design-and-build with an independent qualification consultant. Total programme: 22 months, concept to licensed operation.
- 1
Planning & feasibility
Months 1–5- Product portfolio mapped to +2/+8 °C, −20 °C and controlled ambient zones.
- Redundancy strategy defined for 45 °C+ summer ambient, including N+1 chillers and backup power.
- User Requirement Specification (URS) written before supplier engagement.
Milestone: URS and validation master plan approved.
- 2
Permitting & approvals
Months 5–9- Ministry of Health warehouse licensing pathway agreed and documentation scheduled.
- Civil defence, fire and building approvals for the mixed-temperature envelope.
- Controlled-substance storage and access-control requirements built into the design.
Milestone: Licensing pathway locked with regulator milestones in the project plan.
- 3
Procurement & build-out
Months 9–17- Dual-redundant chiller plant, BMS and 24-hour backup installed.
- Segregated +2/+8 °C and −20 °C rooms constructed inside one building envelope.
- 21 CFR Part 11 compliant monitoring system installed with calibrated sensors.
Milestone: Construction complete, systems energised, IQ documentation issued.
- 4
Testing & validation
Months 17–21- IQ / OQ / PQ executed room by room with an independent qualification team.
- Empty and loaded temperature mapping, plus power-failure and door-open excursion studies.
- SOPs, deviation handling and training records completed for GDP inspection.
Milestone: Zero mapping deviations; validation dossier accepted by the regulator.
- 5
Commissioning & handover
Months 21–22- WHO/GDP commissioning walkthrough with the EPC and quality team.
- Alarm escalation, on-call response and calibration schedule activated.
- First licensed product received under full audit trail.
Milestone: Operating licence granted and facility released for distribution.
This project sits under the Build a Pharmaceutical Cold Chain objective. Start from the objective hub to scope capacity, permitting and budget before engaging suppliers.
Project brief → RFQ package → supplier outreach → outcome
Every ColdMatch project follows the same managed sequence. Nothing reaches a supplier before David has reviewed the brief and confirmed the project scope, budget and timeline.
1. Project brief
- Submitted via
- Pharma cold-chain RFQ — GDP-validated distribution
- Review
- Reviewed manually by David with a GDP validation specialist
Clarified before outreach
- Licence milestones with the Ministry of Health and the validation evidence required.
- Split between +2/+8 °C and −20 °C zones and expected SKU growth over five years.
- Redundancy expectation during 45 °C+ summer ambient conditions.
Qualification checks
- Project value well above threshold (indicated US$ 7–9M).
- Regulatory deadline confirmed in writing, fixing the programme.
- Buyer confirmed a qualified person accountable for validation sign-off.
2. RFQ package issued
Two-envelope RFQ (technical and commercial submitted separately)
Documents in the pack
- URS covering mapping, alarms, access control and 21 CFR Part 11 data integrity.
- Zone schedule for +2/+8 °C and −20 °C areas within one envelope.
- N+1 redundancy and backup-power requirement with hold-time targets.
- Validation deliverables list: IQ/OQ/PQ, mapping protocol, SOP handover.
Mandatory supplier returns
- Redundancy architecture with single-point-of-failure analysis.
- Temperature hold-time under total power loss, with calculation basis.
- Validation resourcing plan and named GDP consultant.
- Commissioning schedule aligned to the licensing date.
3. Managed supplier outreach
- Approached
- 7 EPCs and 2 validation houses screened across the GCC and Europe
- Shortlisted
- 3 EPCs, each paired with an independent validation partner
- Round 1 — GDP evidence
Only suppliers with completed GDP-licensed facilities in high-ambient climates progressed.
- Round 2 — technical tender
Redundancy and hold-time claims stress-tested against the URS in a technical clarification session.
- Round 3 — programme lock
Commissioning and validation dates contractually tied to the licence milestone.
Evaluation weighting
- Regulatory & validation track record
- 35%
- Redundancy and hold-time performance
- 30%
- Programme certainty
- 20%
- Price (normalised scope)
- 15%
4. Commercial outcome
Dual-redundant chiller architecture with an EPC + validation-house pairing
Delivered results
- 99.997% uptime since handover.
- Zero mapping deviations at licensing.
- Licence achieved in 11 months on a US$ 8.6M project.
Run the pharma readiness check, then submit your GDP brief for manual review.
Project records are anonymised at the buyer's request and presented as planning-grade benchmarks. Costs, timelines and performance figures are indicative and are not engineering designs or quotations.
Supplier and manufacturer listings are provided for research, transparency and discovery only. ColdMatch Group does not provide automatic buyer-supplier introductions. Every cold chain project request is reviewed manually by David / ColdMatch Group, and supplier introductions are made only after internal approval.